Results 251 to 260 of about 206,635 (353)
Iron Status and Hemoglobin Level in Chronic Renal Insufficiency
Chi‐yuan Hsu +2 more
openalex +1 more source
Aims This study investigated factors associated with and outcomes of combined loop diuretics with hydrochlorothiazide (HCTZ) for acute decompensated heart failure (ADHF). Methods In this retrospective study, adults hospitalized for ADHF and who received intravenous loop diuretics between January 2016 and March 2023 were enrolled.
Chia‐Chen Hsu +6 more
wiley +1 more source
Aims The aim of this study was to determine the purpose and use of physical examination (PE) in phase 3 and 4 drug interventional clinical trials within type 2 diabetes mellitus. Methods A total of 226 clinical trial protocols identified from the ClinicalTrials.gov database were systematically reviewed by five researchers.
Julia Kopanz +9 more
wiley +1 more source
Safety of gadolinium contrast angiography in patients with chronic renal insufficiency
Albert D. Sam +5 more
openalex +1 more source
Chronic Serial Infusion of Nesiritide Is Not Associated with Worsening Renal Function in Chronic Decompensated Heart Failure Patients with Renal Insufficiency: An Analysis from the FUSION-II Trial [PDF]
Clyde W. Yancy +5 more
openalex +1 more source
Aim Cannabis‐based medicines are gaining interest and being explored for new therapeutic indications, many of which commonly affect older medical patients. As most previous studies of the population pharmacokinetics of cannabinoids have been performed in healthy adults, this study aimed to investigate the population pharmacokinetics of Δ9 ...
Ida Klitzing Storgaard +12 more
wiley +1 more source
Metabolites Associated With Uremic Symptoms in Patients With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. [PDF]
Wulczyn KE +20 more
europepmc +1 more source
Aims Glycogen storage disease type Ib (GSD‐Ib) is a rare genetic disorder causing neutropenia and neutrophil dysfunction in children. G‐CSF has been the primary treatment, but emerging data support the potential of empagliflozin, an SGLT2 inhibitor, as a promising investigational option.
Elizabeth Iwasyk +5 more
wiley +1 more source

